Terms: = Breast cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA
130 results:
1. [Not Available].
Ammar N; Ezzairi F; Omri N; Ammar A; Ezzi O; Ben El Ghali T; Mahjoub M; Chabchoub I; Ben Ahmed S; Njah M
Tunis Med; 2024 Mar; 102(3):157-163. PubMed ID: 38545711
[TBL] [Abstract] [Full Text] [Related]
2. Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment.
Wu J; Wang W; Gao L; Shao X; Wang X
Cancer; 2024 Apr; 130(S8):1449-1463. PubMed ID: 38482921
[TBL] [Abstract] [Full Text] [Related]
3. dnmt3a Cooperates with YAP/TAZ to Drive Gallbladder cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract] [Full Text] [Related]
4. Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer.
Bagheri M; Lee MK; Muller KE; Miller TW; Pattabiraman DR; Christensen BC
Epigenomics; 2024 Mar; 16(5):293-308. PubMed ID: 38356412
[No Abstract] [Full Text] [Related]
5. The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
Toda S; Iwasaki H; Okubo Y; Hayashi H; Kadoya M; Takahashi H; Yokose T; Hiroshima Y; Masudo K
Endocr J; 2024 Jan; 71(1):31-37. PubMed ID: 38044137
[TBL] [Abstract] [Full Text] [Related]
6. Exploring Derivatives of Quinolizidine Alkaloid Sophoridine in the Design and Biological Mechanistic Evaluation of Histone Deacetylase Inhibitors against Triple-Negative breast cancer.
Dai L; Tan C; Wang H; Wang L; Zhang T; Zhi S; Yang Z; Zhao X; Li D
ChemMedChem; 2024 Jan; 19(2):e202300467. PubMed ID: 38031642
[TBL] [Abstract] [Full Text] [Related]
7. Oncolytic Activity of Canine Distemper Virus in Human Ductal breast Carcinoma Cells.
Jhala D; Nathani N; Joshi M; Patel A; Joshi CG
Oncol Res Treat; 2024; 47(1-2):10-17. PubMed ID: 38008084
[TBL] [Abstract] [Full Text] [Related]
8. The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation.
Zhang H; Gao M; Zhao W; Yu L
Breast Cancer Res; 2023 Oct; 25(1):129. PubMed ID: 37885030
[TBL] [Abstract] [Full Text] [Related]
9. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
10. In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated breast cancers.
Santarosa M; Baldazzi D; Armellin M; Maestro R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373065
[TBL] [Abstract] [Full Text] [Related]
11. Clonal Hematopoiesis in Young Women Treated for breast cancer.
Gibson CJ; Fell G; Sella T; Sperling AS; Snow C; Rosenberg SM; Kirkner G; Patel A; Dillon D; Bick AG; Neuberg D; Partridge AH; Miller PG
Clin Cancer Res; 2023 Jul; 29(13):2551-2558. PubMed ID: 37115512
[TBL] [Abstract] [Full Text] [Related]
12. dnmt3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.
Ye D; Wang Y; Deng X; Zhou X; Liu D; Zhou B; Zheng W; Wang X; Fang L
Cell Death Dis; 2023 Feb; 14(2):106. PubMed ID: 36774339
[TBL] [Abstract] [Full Text] [Related]
13. Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies.
Talsania K; Shen TW; Chen X; Jaeger E; Li Z; Chen Z; Chen W; Tran B; Kusko R; Wang L; Pang AWC; Yang Z; Choudhari S; Colgan M; Fang LT; Carroll A; Shetty J; Kriga Y; German O; Smirnova T; Liu T; Li J; Kellman B; Hong K; Hastie AR; Natarajan A; Moshrefi A; Granat A; Truong T; Bombardi R; Mankinen V; Meerzaman D; Mason CE; Collins J; Stahlberg E; Xiao C; Wang C; Xiao W; Zhao Y
Genome Biol; 2022 Dec; 23(1):255. PubMed ID: 36514120
[TBL] [Abstract] [Full Text] [Related]
14. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/dnmt3a/CRTAC1 axis.
He J; Dong C; Zhang H; Jiang Y; Liu T; Man X
Cell Signal; 2023 Feb; 102():110527. PubMed ID: 36410635
[TBL] [Abstract] [Full Text] [Related]
15. MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent cancer Cells through ERK Downregulation.
Bondarev N; Ivanenko K; Khabusheva E; Lebedev T; Manukhov I; Prassolov V
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361596
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Aug; 39(4):1359-1375. PubMed ID: 36241925
[TBL] [Abstract] [Full Text] [Related]
17. CircPTPRM accelerates malignancy of papillary thyroid cancer via miR-885-5p/dnmt3a axis.
Chen D; Jiang X; Luo H; Hua Q; Zhang F
J Clin Lab Anal; 2022 Oct; 36(10):e24688. PubMed ID: 36098040
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner.
Woods ML; Weiss A; Sokol AM; Graumann J; Boettger T; Richter AM; Schermuly RT; Dammann RH
Cancer Gene Ther; 2022 Dec; 29(12):1975-1987. PubMed ID: 35902728
[TBL] [Abstract] [Full Text] [Related]
19. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract] [Full Text] [Related]
20. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
Nicolae A; Bouilly J; Lara D; Fataccioli V; Lemonnier F; Drieux F; Parrens M; Robe C; Poullot E; Bisig B; Bossard C; Letourneau A; Missiaglia E; Bonnet C; Szablewski V; Traverse-Glehen A; Delfau-Larue MH; de Leval L; Gaulard P
Mod Pathol; 2022 Aug; 35(8):1126-1136. PubMed ID: 35301414
[TBL] [Abstract] [Full Text] [Related]
[Next]